Among children who were not already shedding virus at baseline, the incidence of laboratory-confirmed clinical influenza was reduced from 21 % (15/ 70) in the group not receiving prevention to 4 % (2/ 47) in the group receiving prevention (80.1 % reduction [ 95 % CI 22.0 – 94.9; p = 0.0206 ]). The NNT for the total paediatric population was 9 (95 % CI 7 – 24) and
V študiji se je incidenca klinične laboratorijsko potrjene influence pri otrocih, ki še niso imeli virusa na začetku, zmanjšala iz 21 % (15/ 70) v skupini, ki ni prejemala zdravila za preprečevanje, na 4 % (2/ 47) v skupini, ki je prejemala zdravilo za preprečevanje gripe (80, 1 - % zmanjšanje [ 95 - % interval zaupanja 22, 0– 94, 9; p = 0, 0206 ]).